Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07599228 · ClinicalTrials.gov registry record · NA
Using Virtual Reality to Teach Mindfulness to People With Migraine
A NA study, sponsored by Brigham and Women's Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT07599228 is a NA study that has not yet begun recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 160 participants.
The verdict
NCT07599228, a NA study, has not yet begun recruiting, sponsored by Brigham and Women's Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
The aim of this clinical trial is to learn if people with migraine can learn a type of biobehavioral therapy called Acceptance and Commitment Therapy (ACT) by using a virtual reality headset. Researchers are studying if this type of mindfulness therapy helps to decrease migraine-related disability. Participants will be randomized to treatment as usual or active virtual reality groups for four weeks. Everyone will keep symptom diaries, complete surveys, attend two clinic visits, and have two blood draws.
Interventions
- BEHAVIORAL ACT therapy delivered by REACT NeuroVR headset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2026-07 |
| Est. Completion | 2031-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07599228
The ClinicalTrials.gov registry entry for NCT07599228 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ACT therapy delivered by REACT NeuroVR headset is the first listed.
NCT07599228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07599228 about?
NCT07599228 is a clinical study titled "Using Virtual Reality to Teach Mindfulness to People With Migraine". The aim of this clinical trial is to learn if people with migraine can learn a type of biobehavioral therapy called Acceptance and Commitment Therapy (ACT) by using a virtual reality headset. Researchers are studying if this type of mindfulness therapy helps to decrease migraine-related disability. ...
What is the current status of trial NCT07599228?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2026-07. Estimated completion is 2031-01.
What interventions are being tested in trial NCT07599228?
The interventions under investigation include: ACT therapy delivered by REACT NeuroVR headset (BEHAVIORAL).
Who is sponsoring clinical trial NCT07599228?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.